Neuroprotective effect of MALAT1 in hypoxic preconditioned mice

  • WANG Liping ,
  • JIANG Shuyuan ,
  • SHAO Guo
Expand
  • 1. School of Basic Medicine and Forensic Medicine, Baotou Medical College, Baotou 014060, China;
    2. Inner Mongolia Key Laboratory of Hypoxia Adaptive Translational Medicine, Baotou Medical College;
    3. School of Pharmacy, Baotou Medical College;
    4. Center for Translational Medicine, The Third People's Hospital of Longgang District

Received date: 2023-02-18

  Online published: 2023-08-28

Abstract

Objective: To study the molecular mechanism of hypoxic preconditioning on the protection of hypoxia injury by altering the expression of MALAT1. Methods: A total of 90 ICR mice (18 ~ 22g, 6 ~ 8 weeks) were randomly divided into three groups: Control group (n=30), Hypoxic group (n=30), and Hypoxic preconditioning (HPC) group (n=30). The mRNA level of MALAT1 in the hippocampus of mice was detected by qPCR. MALAT1 was knocked down by siRNA in HT22 cells, and then H/R (Hypoxia/Reoxygenation) injury was performed on HT22 cells. The mRNA level of MALAT1 was detected by QPCR after knockdown of MALAT1 in HT22 cells. The expression changes of Cleaved Caspase-3 and cell death rate after knockdown of MALAT1 in HT22 cells followed by H/R injury were detected by Western blot and live cell workstation. Results: Compared with Group C, the expression of MALAT1 in hypoxia group was significantly increased (P<0.05), and the expression of MALAT1 in HPC group was recovered (P<0.05) . Compared with NC Group, the mRNA expression level of MALAT1 in siMALAT1 group decreased (P<0.05). The expression level of Cleaved Caspase-3 in siMALAT1 + H/R group was significantly higher than that in siMALAT1 and H/R groups (P<0.05). Compared with H/R group, the cell death rate of siMALAT1 + H/R group was significantly higher (P<0.05). Conclusion: Hypoxic preconditioning may play a neuroprotective role by changing the expression of MALAT1 and decreasing apoptosis induced by hypoxia.

Cite this article

WANG Liping , JIANG Shuyuan , SHAO Guo . Neuroprotective effect of MALAT1 in hypoxic preconditioned mice[J]. Journal of Baotou Medical College, 2023 , 39(8) : 6 -11 . DOI: 10.16833/j.cnki.jbmc.2023.08.002

References

[1] Durukan A, Tatlisumak T. Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection[J].Exp Transl Stroke Med, 2010, 2(1):2.
[2] Peng K, Tan D, He M, et al. Studies on cerebral protection of digoxin against hypoxic-ischemic brain damage in neonatal rats[J].Neuroreport, 2016, 27(12):906-915.
[3] Pacary E, Petit E, Bernaudin M. Erythropoietin, a cytoprotective and regenerative cytokine, and the hypoxic brain[J].Neurodegener Dis, 2006, 3(1/2):87-93.
[4] Li S, Hafeez A, Noorulla F, et al. Preconditioning in neuroprotection: from hypoxia to ischemia[J].Prog Neurobiol, 2017, 157(1):79-91.
[5] Statello L, Guo CJ, Cen LL, et al. Gene regulation by long non-coding RNAs and its biological functions[J].Nat Rev Mol Cell Biol, 2021, 22(2):96-118.
[6] Wang H, Zheng X, Jin J, et al. LncRNA MALAT1 silencing protects against cerebral ischemia-reperfusion injury through miR-145 to regulate AQP4[J].J Biomed Sci, 2020, 27(1):40.
[7] Stone JK, Kim JH, Vukadin L, et al. Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells[J].J Biol Chem, 2019, 294(29):11213-11224.
[8] Luo T, Zhang H, Zhang WW, et al. Neuroprotective effect of Jatrorrhizine on hydrogen peroxide-induced cell injury and its potential mechanisms in PC12 cells[J].Neurosci Lett, 2011, 498(3):227-231.
[9] Xing Y, Bai Y. A review of exercise-induced neuroplasticity in ischemic stroke: pathology and mechanisms[J].Mol Neurobiol, 2020, 57(10):4218-4231.
[10] Jiang X, Andjelkovic AV, Zhu L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke[J].Prog Neurobiol, 2018, 163/164(10):144-171.
[11] Nakamura A, Otani K, Shichita T. Lipid mediators and sterile inflammation in ischemic stroke[J].Int Immunol, 2020, 32(11):719-725.
[12] Wang SW, Liu Z, Shi ZS. Non-coding RNA in acute ischemic stroke: mechanisms, biomarkers and therapeutic targets[J].Cell Transplant, 2018, 27(12):1763-1777.
[13] Salle-Lefort S, Miard S, Nolin M A, et al. Hypoxia upregulates Malat1 expression through a CaMKK/AMPK/HIF-1α axis[J].Int J Oncol, 2016, 49(4):1731-1736.
[14] Meng S, Wang B, Li W. LncRNA MALAT1 improves cerebral ischemia-reperfusion injury and cognitive dysfunction by regulating miR-142-3p/SIRT1 axis[J].Int J Neurosci, 2021:1-14.
[15] Liu H, Wei Z, Sun X, et al. MALAT1 improves functional recovery after traumatic brain injury through promoting angiogenesis in experimental mice[J].Brain Res, 2022, 1775(6):147731.
[16] Tan X, Guo W, Peng Z, et al. LncRNA-Malat1 down-regulates miR-211-5p expression to promote neuronal damage from cerebral ischemia reperfusion injury[J].Biochem Pharmacol, 2021, 192(21):114694.
[17] Zhang G, Wang Q, Su D, et al. Long non-coding RNAMALAT1 knockdown alleviates cerebral ischemia/reperfusion injury of rats through regulating the miR-375/PDE4D axis[J].Front Neurol, 2020, 11(11):578765.
Outlines

/